DE69905380D1 - Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen - Google Patents
Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffenInfo
- Publication number
- DE69905380D1 DE69905380D1 DE69905380T DE69905380T DE69905380D1 DE 69905380 D1 DE69905380 D1 DE 69905380D1 DE 69905380 T DE69905380 T DE 69905380T DE 69905380 T DE69905380 T DE 69905380T DE 69905380 D1 DE69905380 D1 DE 69905380D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- powder
- active substance
- sieve
- therapeutically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801143 | 1998-09-10 | ||
PCT/DK1999/000480 WO2000015195A1 (en) | 1998-09-10 | 1999-09-10 | Quick release pharmaceutical compositions of drug substances |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69905380D1 true DE69905380D1 (de) | 2003-03-20 |
DE69905380T2 DE69905380T2 (de) | 2003-11-27 |
Family
ID=8101500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69905380T Expired - Lifetime DE69905380T2 (de) | 1998-09-10 | 1999-09-10 | Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6713089B1 (de) |
EP (1) | EP1109534B1 (de) |
JP (2) | JP5026635B2 (de) |
AT (1) | ATE232382T1 (de) |
AU (1) | AU5504599A (de) |
CA (1) | CA2343148C (de) |
DE (1) | DE69905380T2 (de) |
DK (1) | DK1109534T3 (de) |
EA (1) | EA004032B1 (de) |
ES (1) | ES2190241T3 (de) |
PT (1) | PT1109534E (de) |
TR (1) | TR200100708T2 (de) |
WO (1) | WO2000015195A1 (de) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US8231899B2 (en) * | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
EP1250921A1 (de) * | 2001-04-21 | 2002-10-23 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Schnell zerfallende Meloxicam enthaltende Tablette |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US20030161875A1 (en) * | 2002-02-27 | 2003-08-28 | Deepak Murpani | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
US20040202717A1 (en) * | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
JP2009513512A (ja) * | 2003-07-09 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | メロキシカムを含む組成物 |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1568369A1 (de) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen |
US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2572359C (en) * | 2004-06-29 | 2010-08-03 | Nycomed Danmark Aps | Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
JP5490347B2 (ja) * | 2005-05-27 | 2014-05-14 | エスエス製薬株式会社 | 経口投与用製剤 |
JO3352B1 (ar) | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
US20100204333A1 (en) | 2005-07-20 | 2010-08-12 | Panacea Biotec Ltd. | Novel Pharmaceutical Modified Release Dosage Form Cyclooxygenase Enzyme Inhibitor |
BRPI0613611A2 (pt) * | 2005-07-22 | 2011-01-18 | Myriad Genetics Inc | formulações de alta concentração de fármaco e formas de dosagens |
CN103214483B (zh) | 2005-12-13 | 2014-12-17 | 因塞特公司 | 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶 |
US20070154542A1 (en) * | 2005-12-30 | 2007-07-05 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
WO2007130507A2 (en) * | 2006-05-03 | 2007-11-15 | Proethic Pharmaceuticals, Inc. | Acute pain medications based on fast acting diclofenac-opioid combinations |
WO2008008120A1 (en) * | 2006-07-14 | 2008-01-17 | Fmc Corporation | Solid form |
WO2008062449A2 (en) * | 2006-09-18 | 2008-05-29 | Glenmark Pharmaceuticals Limited | A novel pharmaceutical soft gel composition containing dexibuprofen and paracetamol |
US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
EP2740731B1 (de) | 2007-06-13 | 2016-03-23 | Incyte Holdings Corporation | Kristalline Salze des Janus-Kinasehemmers (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-YL)-1H-pyrazol-1-YL)-3-cyclopentylpropanenitril |
WO2009034558A2 (en) | 2007-09-14 | 2009-03-19 | Wockhardt Research Centre | Rhein or diacerein compositions |
WO2009089134A1 (en) | 2008-01-04 | 2009-07-16 | Src, Inc. | Methods for measuring a patint response upon administration of a drug and compositions thereof |
AU2009249069A1 (en) | 2008-05-20 | 2009-11-26 | Neurogesx, Inc. | Carbonate prodrugs and methods of using the same |
AU2009249067A1 (en) | 2008-05-20 | 2009-11-26 | Neurogesx, Inc. | Water-soluble acetaminophen analogs |
AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
DK2432472T3 (da) | 2009-05-22 | 2019-11-18 | Incyte Holdings Corp | 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octan- eller heptan-nitril som jak-inhibitorer |
JP2012531430A (ja) * | 2009-06-25 | 2012-12-10 | ポーゼン インコーポレイテッド | アスピリン療法を必要とする患者を治療するための方法 |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
TW201113285A (en) * | 2009-09-01 | 2011-04-16 | Incyte Corp | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
US9101529B2 (en) | 2009-10-12 | 2015-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
WO2011107150A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
KR102283091B1 (ko) | 2010-03-10 | 2021-07-30 | 인사이트 홀딩스 코포레이션 | Jak1 저해제로서의 피페리딘4일 아제티딘 유도체 |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
EP2574168B9 (de) | 2010-05-21 | 2016-10-05 | Incyte Holdings Corporation | Topische formulierung für einen jak-hemmer |
EP2394641A1 (de) | 2010-05-30 | 2011-12-14 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmazeutische Formulationen von Lornoxicam |
AR083933A1 (es) | 2010-11-19 | 2013-04-10 | Incyte Corp | Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak |
JP5917544B2 (ja) | 2010-11-19 | 2016-05-18 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン |
WO2012146314A1 (en) | 2011-04-29 | 2012-11-01 | Refarmed Chemicals Sa | Thin gelatin capsules for rapid drug release in the mouth |
CN103797010B (zh) | 2011-06-20 | 2016-02-24 | 因塞特控股公司 | 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物 |
TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為jak抑制劑之環己基氮雜環丁烷衍生物 |
UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
JP2012012411A (ja) * | 2011-10-03 | 2012-01-19 | Ssp Co Ltd | 経口投与用製剤 |
CA2860231A1 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
BR112014024382B1 (pt) | 2012-04-18 | 2022-08-09 | SpecGx LLC | Composições farmacêuticas de contenção de abuso de liberação imediata e seu processo de preparação |
US9308196B2 (en) * | 2012-05-18 | 2016-04-12 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam |
US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
US20130310435A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
US9193733B2 (en) | 2012-05-18 | 2015-11-24 | Incyte Holdings Corporation | Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors |
CR20190073A (es) | 2012-11-15 | 2019-04-25 | Incyte Holdings Corp | FORMAS DE DOSIFICACIÓN DE RUXOLITINIB DE LIBERACIÓN SOTENIDA (Divisional 2015-265) |
RS62867B1 (sr) | 2013-03-06 | 2022-02-28 | Incyte Holdings Corp | Postupci i intermedijeri za dobijanje inhibitora jak |
WO2014152296A1 (en) | 2013-03-15 | 2014-09-25 | Mallinckrodt Llc | Abuse deterrent solid dosage form for immediate release with functional score |
JP2013216701A (ja) * | 2013-07-29 | 2013-10-24 | Ssp Co Ltd | 経口投与用製剤 |
KR101890649B1 (ko) * | 2013-07-30 | 2018-09-28 | 라이온 가부시키가이샤 | 정제 |
EP3030227B1 (de) | 2013-08-07 | 2020-04-08 | Incyte Corporation | Dosierungsformen mit anhaltender freisetzung für einen jak1-inhibitor |
US9498467B2 (en) | 2014-05-30 | 2016-11-22 | Incyte Corporation | Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1 |
JP6850131B2 (ja) | 2014-07-03 | 2021-03-31 | スペックジーエックス エルエルシー | 非セルロース多糖を含む、乱用抑止性即時放出製剤 |
WO2017048720A1 (en) | 2015-09-15 | 2017-03-23 | Praxis Biosciences, Llc | Prodrugs of fencamfamine |
UA126916C2 (uk) | 2017-04-27 | 2023-02-22 | Др. Редді'З Лабораторіз Лімітед | Фармацевтична композиція кеторолаку |
AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
PE20211310A1 (es) | 2018-01-30 | 2021-07-22 | Incyte Corp | Procedimiento para la elaboracion de un recipiente de vidrio de sosa-cal a partir de materiales formadores de vidrio 100% reciclados y un recipiente de vidrio elaborado a partir de dicho procedimiento |
JP2021519775A (ja) | 2018-03-30 | 2021-08-12 | インサイト・コーポレイションIncyte Corporation | Jak阻害剤を用いる化膿性汗腺炎の治療 |
JP7170437B2 (ja) * | 2018-06-29 | 2022-11-14 | 小林製薬株式会社 | 内服用医薬組成物 |
MX2021002459A (es) | 2018-09-25 | 2021-04-29 | SpecGx LLC | Formas de dosificacion en capsula disuasorias del abuso de liberacion inmediata. |
US11779541B2 (en) * | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
CN115038443A (zh) | 2019-11-22 | 2022-09-09 | 因西特公司 | 包含alk2抑制剂和jak2抑制剂的组合疗法 |
JP7499025B2 (ja) | 2019-12-27 | 2024-06-13 | 小林製薬株式会社 | 内服用医薬組成物 |
US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
JP2023534810A (ja) | 2020-07-15 | 2023-08-14 | シャバー リサーチ アソシエイツ エルエルシー | 急性痛の処置並びに胸やけの重症度及び/又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965072A (en) * | 1988-11-03 | 1990-10-23 | Miles Inc. | Granulating composition and method |
US5219574A (en) * | 1989-09-15 | 1993-06-15 | Cima Labs. Inc. | Magnesium carbonate and oil tableting aid and flavoring additive |
JP2906528B2 (ja) * | 1990-02-14 | 1999-06-21 | 大正製薬株式会社 | 吸収を促進した内服用固形製剤 |
CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
JP3069458B2 (ja) * | 1992-01-29 | 2000-07-24 | 武田薬品工業株式会社 | 口腔内崩壊型錠剤およびその製造法 |
BR9507768A (pt) * | 1994-05-27 | 1997-09-02 | Farmarc Nederland Bv | Composição farmacêutica |
ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
-
1999
- 1999-09-10 EA EA200100331A patent/EA004032B1/ru not_active IP Right Cessation
- 1999-09-10 US US09/786,864 patent/US6713089B1/en not_active Expired - Lifetime
- 1999-09-10 JP JP2000569779A patent/JP5026635B2/ja not_active Expired - Lifetime
- 1999-09-10 DK DK99941418T patent/DK1109534T3/da active
- 1999-09-10 EP EP99941418A patent/EP1109534B1/de not_active Expired - Lifetime
- 1999-09-10 WO PCT/DK1999/000480 patent/WO2000015195A1/en active IP Right Grant
- 1999-09-10 PT PT99941418T patent/PT1109534E/pt unknown
- 1999-09-10 CA CA002343148A patent/CA2343148C/en not_active Expired - Lifetime
- 1999-09-10 DE DE69905380T patent/DE69905380T2/de not_active Expired - Lifetime
- 1999-09-10 ES ES99941418T patent/ES2190241T3/es not_active Expired - Lifetime
- 1999-09-10 AT AT99941418T patent/ATE232382T1/de active
- 1999-09-10 TR TR2001/00708T patent/TR200100708T2/xx unknown
- 1999-09-10 AU AU55045/99A patent/AU5504599A/en not_active Abandoned
-
2011
- 2011-10-14 JP JP2011227314A patent/JP5622703B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6713089B1 (en) | 2004-03-30 |
EP1109534A1 (de) | 2001-06-27 |
CA2343148A1 (en) | 2000-03-23 |
ES2190241T3 (es) | 2003-07-16 |
ATE232382T1 (de) | 2003-02-15 |
JP5026635B2 (ja) | 2012-09-12 |
DK1109534T3 (da) | 2003-06-10 |
PT1109534E (pt) | 2003-06-30 |
WO2000015195A1 (en) | 2000-03-23 |
JP2002524492A (ja) | 2002-08-06 |
EP1109534B1 (de) | 2003-02-12 |
EA200100331A1 (ru) | 2001-08-27 |
DE69905380T2 (de) | 2003-11-27 |
TR200100708T2 (tr) | 2001-07-23 |
AU5504599A (en) | 2000-04-03 |
JP5622703B2 (ja) | 2014-11-12 |
JP2012082197A (ja) | 2012-04-26 |
EA004032B1 (ru) | 2003-12-25 |
CA2343148C (en) | 2005-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69905380T2 (de) | Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen | |
ES2543427T3 (es) | Forma farmacéutica oral de deferasirox | |
DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
SK5672001A3 (en) | Improved fast disintegrating tablet | |
DK1441704T3 (da) | Orodispersibel tablet med höj homogenitet og fremgangsmåde til fremstilling heraf | |
HUP0000116A2 (hu) | Íz-maszkírozott mikrokapszulás készítmények és a gyártásukra szolgáló eljárások | |
WO2002043702A3 (en) | Pharmaceutical compositions for inhalation | |
DE69934135D1 (de) | Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen | |
HUP9801615A2 (hu) | Szimetikon/vízmentes kalcium-foszfát-kompozíciók | |
NO20001670L (no) | Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter | |
ATE164060T1 (de) | Inhalationspulver und verfahren zu ihrer herstellung | |
EA200601588A1 (ru) | Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств | |
EA200400045A1 (ru) | Система для ингаляции сухим порошком для транспульмонарного применения | |
EP2298279A3 (de) | Pharmazeutische Zusammensetzungen zur Inhalation | |
KR960021061A (ko) | 경구 투여용 약제학적 조성물 | |
Zimm et al. | Drug release from a multiparticulate pellet system | |
JP2004513093A5 (de) | ||
CY1113221T1 (el) | Διεργασια για την παρασκευη ενος φαρμακου | |
DE69408122T2 (de) | Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren | |
JP3274416B2 (ja) | 口腔内崩壊性粒状製剤 | |
DE69428455D1 (de) | Verfahren zur herstellung von niedrigdosierten arzneimitteln | |
WO2003028624A3 (en) | Levothyroxine compositions and methods | |
Guo et al. | Investigation of the release of aspirin from spray-congealed micro-pellets | |
JP2789115B2 (ja) | 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法 | |
JP3240593B2 (ja) | 可溶性コラーゲンパウダーを担体とする医薬徐放剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NYCOMED DANMARK APS, ROSKILDE, DK |